Randomized controlled trial comparing radiotherapy plus /- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG0401

被引：0
|
作者：
Yokomizo, A. [1 ]
Satoh, T. [2 ]
Hashine, K. [3 ]
Inoue, T. [4 ]
Fujimoto, K. [5 ]
Egawa, S. [6 ]
Habuchi, T. [7 ]
Kawashima, K. [8 ]
Ishizuka, O. [9 ]
Shinohara, N. [10 ]
Sugimoto, M. [11 ]
Yoshino, Y. [12 ]
Wakabayashi, M. [13 ]
Nihei, K. [14 ]
Fukuda, H. [13 ]
Tobisu, K-I. [15 ]
Kakehi, Y.
Naito, S. [1 ]
机构：
[1] Harasanshin Hosp, Urol, Fukuoka, Japan
[2] Kitasato Univ, Urol, Sch Med, Sagamihara, Kanagawa, Japan
[3] Natl Hosp Org, Urol, Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[4] Kyoto Univ, Urol, Kyoto, Japan
[5] Nara Med Univ, Urol, Nara, Japan
[6] Jikei Univ Hosp, Urol, Tokyo, Japan
[7] Akita Univ, Urol, Grad Sch Med, Akita, Japan
[8] Tochigi Canc Ctr, Urol, Utsunomiya, Tochigi, Japan
[9] Shinshu Univ, Urol, Sch Med, Matsumoto, Japan
[10] Hokkaido Univ Hosp, Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan
[11] Kagawa Univ, Urol, Fac Med, Takamatsu, Kagawa, Japan
[12] Nagoya Univ, Urol, Grad Sch Med, Nagoya, Aichi, Japan
[13] Natl Canc Ctr, JCOG Data Ctr, Operat Off, Tokyo, Japan
[14] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Radiat Oncol, Tokyo, Japan
[15] Komagome Hosp, Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
788PD
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Randomized controlled trial to evaluate radiotherapy±endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy:: Japan Clinical Oncology Group Study JCOG 0401
    Yokomizo, A
    Kawamoto, H
    Nihei, K
    Ishizuka, N
    Kakehi, Y
    Tobisu, K
    Naito, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (01) : 34 - 36
  • [2] Salvage Radiotherapy Versus Hormone Therapy for Prostate -specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open -label, Phase 3 Trial (JCOG0401)
    Yokomizo, Akira
    Wakabayashi, Masashi
    Satoh, Takefumi
    Hashine, Katsuyoshi
    Inoue, Takahiro
    Fujimoto, Kiyohide
    Egawa, Shin
    Habuchi, Tomonori
    Kawashima, Kiyotaka
    Ishizuka, Osamu
    Shinohara, Nobuo
    Sugimoto, Mikio
    Yoshino, Yasushi
    Nihei, Keiji
    Fukuda, Haruhiko
    Tobisu, Ken-ichi
    Kakehi, Yoshiyuki
    Naito, Seiji
    EUROPEAN UROLOGY, 2020, 77 (06) : 689 - 698
  • [3] A Randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: Results at median follow-up of 102 months
    Akakura, Koichiro
    Suzuki, Hiroyoshi
    Ichikawa, Tomohiko
    Fujimoto, Hiroyuki
    Maeda, Osamu
    Usami, Michiyuki
    Hirano, Daisaku
    Takimoto, Yukie
    Kamoto, Toshiyuki
    Ogawa, Osamu
    Sumiyoshi, Yoshiteru
    Shimazaki, Jun
    Kakizoe, Tadao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (12) : 789 - 793
  • [4] A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017
    Shien, Tadahiko
    Nakamura, Kenichi
    Shibata, Taro
    Kinoshita, Takayuki
    Aogi, Kenjiro
    Fujisawa, Tomomi
    Masuda, Norikazu
    Inoue, Kenichi
    Fukuda, Haruhiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 970 - 973
  • [5] A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017.
    Shien, Tadahiko
    Hara, Fumikata
    Aogi, Kenjiro
    Yanagita, Yasuhiro
    Tsuneizumi, Michiko
    Yamamoto, Naohito
    Matsumoto, Hiroshi
    Suto, Akihiko
    Watanabe, Kenichi
    Harao, Michiko
    Kanbayashi, Chizuko
    Ito, Mitsuya
    Kadoya, Takayuki
    Anan, Keisei
    Maeda, Shigeto
    Sasaki, Keita
    Ogawa, Gakuto
    Fukuda, Haruhiko
    Iwata, Hiroji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)
    Tohi, Yoichiro
    Yokomizo, Akira
    Kimura, Takahiro
    Wakabayashi, Masashi
    Shiota, Masaki
    Mori, Keiichiro
    Kato, Takuma
    Tsuzuki, Toyonori
    Kato, Masashi
    Sasaki, Keita
    Kawahara, Takashi
    Eto, Masatoshi
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Sugimoto, Mikio
    Urologic Oncology Study Grp Japan Clinical Oncology Grp
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [7] Health-related quality of life results in pathologic stage C prostate cancer from a southwest oncology group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    Moinpour, Carol M.
    Hayden, Katherine A.
    Unger, Joseph M.
    Thompson, Ian M., Jr.
    Redman, Mary W.
    Canby-Hagino, Edith D.
    Higgins, Betsy A.
    Sullivan, Jerry W.
    Lemmon, Dianne
    Breslin, Sheila
    Crawford, E. David
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 112 - 120
  • [8] Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
    Ohtsu, A
    Shimada, Y
    Shirao, K
    Boku, N
    Hyodo, I
    Saito, H
    Yamamichi, N
    Miyata, Y
    Ikeda, N
    Yamamoto, S
    Fukuda, H
    Yoshida, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 54 - 59
  • [9] A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 study; PRIM-BC)
    Shien, Tadahiko
    Iwata, Hiroji
    Nakamura, Kenichi
    Kinoshita, Takayuki
    Hara, Fumikata
    Fujisawa, Tomomi
    Masuda, Norikazu
    Inoue, Kenichi
    Shibata, Taro
    Fukuda, Haruhiko
    CANCER RESEARCH, 2015, 75
  • [10] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Katayama, Hiroshi
    Ueno, Makoto
    Ikeda, Masafumi
    Ishii, Hiroshi
    Azuma, Takeshi
    Iguchi, Haruo
    Nakamori, Shoji
    Mizuno, Nobumasa
    Sata, Naohiro
    Sugimori, Kazuya
    Yamaguchi, Konsei
    Mine, Tetsuya
    Sano, Keiji
    Maguchi, Hiroyuki
    Shimizu, Kyoko
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345